KXAN Radio News, Austin, Nov. 2, 2006 http://www.kxan.com/Global/story.asp?S=5532735&nav=menu73_6_4_6 A new class of diabetes drugs appears to hold promise against sepsis, Texas researchers report. In animal studies, giving a compound from the family of aldose reductase inhibitors stopped the deadly inflammation of sepsis, which is caused by the overreaction of the immune system to a bacterial infection, according to a report in the Oct. online issue of Circulation.